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Paracelsus in nanotoxicology
Dominique Lison*, Giulia Vietti and Sybille van den Brule
Nanotoxicology came to light in the years 2000, and rap-
idly became The Eldorado in toxicology, attracting many
investigators, notably because significant public funding
was available to address the growing health concerns
posed by nanomaterials (NM) and their technological
applications. Almost 10,000 publications dealing with
the toxicity of NM are currently referenced in PubMed,
and citation metrics reflect an enthusiastic activity of the
nanotoxicology community. The most highly cited pa-
pers in toxicology journals are almost exclusively dealing
with NM, e.g. among the 10 most cited publications in
Particle and Fibre Toxicology identified in May 2014,
nine are about NM. This blooming enthusiasm for nano-
toxicology has been a source of inspiration for many
scientists, leading to innovative methodological develop-
ments, new findings and discoveries and we are cur-
rently beginning to discern how NM interact with cells,
biological tissues and their components. It is, however,
fair to acknowledge that nanotoxicology has not yet de-
livered the results expected by regulators and public au-
thorities. Voices have even questioned the usefulness
and scientific validity of many nanotoxicology data pro-
duced in recent years [1]. Recommendations have been
made to improve nanotoxicology methods and the qual-
ity of research [2]. A first step was addressed by improv-
ing NM characterization. The necessity to carefully
assess, describe and report the physicochemical charac-
teristics of the NM investigated experimentally has been
acknowledged early on [3,4] and most editorial boards
will currently not accept publishing a manuscript that
does not include a decent characterization of the test
materials. The challenge for nanotoxicologists is now to
use this physicochemical information to decipher the
complex mechanisms of nanoparticle toxicity.
Another source of debate is related to the definition
and expression of the dose in nanotoxicology. After
500 years, the famous dictum of Paraceslus “Dosis Sola
Facit Venenum” is still a key concept in modern toxicol-
ogy, but it has not been easily integrated in the field of
nanotoxicology. In this commentary, we focus on the
very basic but complex aspects of dose and dosimetry in
in vitro nanotoxicology. In the following section, we de-
scribe and define important terms and concepts related
to this issue.
Exposure is generally defined as a condition entailing a
possibility for an agent to enter in contact with a biological
target, an organism, a tissue or a cell. The dose is defined as
the amount of agent which enters in contact with the bio-
logical target (as a consequence of exposure). A metric is a
standard of measurement, a way of expressing exposure or
dose. Many metrics have been proposed in nanotoxicology,
including μg/ml, cm2/ml, μg/cm2, number particles/ml, …
for in vitro measurements. Dosimetry is the accurate meas-
urement of the dose.
An accurate definition of the dose is needed to identify
and characterize dose-effect and dose–response relation-
ships that contribute to characterize the hazard of a
chemical. It can, in principle, be expected that the closer
to the effect the dose is defined, the more accurate will
be the dose-effect/response relationships. In conven-
tional toxicology, it is, therefore, usually preferred to use
biologically effective (delivered, cell-associated or intra-
cellular) doses compared to nominal dose or exposure.
In particle toxicology, and notably in nanotoxicology,
we are dealing with solid materials that may have differ-
ent modes of interaction with the cells, and defining the
biologically effective dose is not a trivial issue (Figure 1).
In nanotoxicology, the dose is defined by default as the
nominal dose, i.e. the amount of NM introduced into
the culture medium, but the possibility exists to also
measure deposited, cell-associated or intracellular doses.
Delivered or cellular doses in nanotoxicology are condi-
tioned by the very specific behavior of nanoparticles in
biological media, notably in cell culture medium. Their
movements and deposition in biological fluids are deter-
mined by different forces including diffusion, gravitation
and convection, the relative importance of which varying
with the particle shape, surface charge, size and/or dens-
ity as well as with the composition of the medium [5].
Nanoparticles tend to agglomerate and aggregate to re-
duce their surface energy and bind biomolecules that
modify their surface characteristics. As a consequence,* Correspondence: dominique.lison@uclouvain.be
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investigators have rapidly realized that NM are signifi-
cantly modified, both qualitatively and quantitatively, be-
fore entering in contact with the cells at the bottom of
the culture well. Qualitative modifications are addressed
by investigating surface adsorption of biomolecules from
the culture medium, leading to the formation of the so-
called (protein) corona [6,7]. Efforts are now directed
at characterizing the NM in the test medium, not only
before the experiment but possibly also in operando
(during or at the end of the experiment) [8]. In addition,
cultured cells produce biomolecules that may interact
with NM and possibly modify their behavior in suspen-
sion [9]. Quantitative aspects are addressed by several
investigators who realized the need for a closer attention
to the dosimetry of nanoparticles in vitro. This led to
the development of the “particokinetics” concept [10],
and studies trying to delineate the biologically effective
dose of nanoparticles [5,11].
The matter remains, however, tricky and there is
probably no one-fits-all approach to address dosimetric
questions in nanotoxicology. We highlight here the com-
plexity of these issues in an effort to guide the selection
of most appropriate dose metrics, according to the re-
search question, the NM investigated and the endpoint
of toxicity considered.
1. Considering delivered and cellular doses.
Investigators should now systematically consider the
possibility that the nominal dose might not be
sufficiently accurate to characterize dose-effect/
response relationships, and should examine the dose
delivered to the cells, or the (intra)cellular doses.
The delivered dose can be estimated by modelling
[12,13] and some researchers have started reporting
dose-effect relationships with these parameters
instead of the conventional nominal dose [14,15].
It should also be considered that the cellular uptake
of NM is an active process that can be influenced
by the type and activation state of the cultured
cells. The uptake of nanoparticles by cultured
J774 macrophages is e.g. increased after priming
with LPS [14]. Cell density is another parameter
to consider as it will obviously affect the cellular
dose, leading to reduced cytotoxicity at higher cell
density [16]. The cell-associated or intracellular
doses can often be determined by quantifying
the NM or a representative component, and a
range of methods are available in function of
the NM considered, including chemical analysis,
fluorescence, luminescence, radioactivity or
spectroscopy.
2. But, the cellular dose is not always the most relevant.
The biologically effective dose might in some cases
be extracellular like for zinc oxide nanoparticles
which mainly exert their cytotoxic activity through
the release of Zn(II) cations [17]. More complex
mechanisms have, however, been reported for other
metallic nanoparticles such as copper [18] and
cobalt oxide [19], involving the cellular uptake of the
nanoparticles and the subsequent intracellular
release of toxic cations (Trojan horse mechanism).
Based on this mechanistic knowledge, one might
Figure 1 Biologically effective doses in in vitro nanotoxicology.
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wish to preferably rely on the nominal dose for ZnO
nanoparticles (reflecting extracellular Zn(II) ions),
and on the intracellular dose for CoO and CuO
nanoparticles. Other NM act by interacting with the
cell membrane and some specific receptors [20],
suggesting that cell uptake is not critical for
mediating the toxic effect, hence the deposited or
cell-associated dose should be considered as the
most relevant. On other occasions, the toxicity of
nanoparticles might be mediated by their capacity
to modify the culture medium, e.g. by depleting it
from essential nutrients [21] or by activating some
biomolecules [22], which might again suggest that
the nominal dose would be more appropriate to
account for the cytotoxic activity. Knowledge of the
mechanism of toxicity, obtained experimentally or
deduced by analogy with a similar NM, is therefore
essential to guide the investigators selecting the most
relevant dose to characterize dose-effect/response
relationships.
3. Disperse or not?
Most investigators in nanotoxicology take great care
to adequately disperse the nanoparticles in culture
medium by adding chemical dispersants and/or
using mechanical dispersion such as sonication. This
practice should be examined critically on a case by
case basis to determine whether NM really need to
be dispersed before cell exposure and whether this is
relevant for real exposure and/or effects under
study. It is indeed well-known that nanoparticles in
the air, in water or in food are largely aggregated/
agglomerated, and the relevance of exposing cells to
well-dispersed suspensions that do not occur in
the “real life” might be questioned. One might also
wish to ask whether the cellular response is actually
affected by the dispersion state. This issue remains
an apparent puzzle because some authors found that
the formation of aggregates reduces the cytotoxic
activity of NM, whereas others did not observe an
influence of the aggregation/agglomeration state.
The heterogeneity of these findings might, in part,
be explained by considering that some studies
used chemicals to disperse the nanoparticles in
suspensions [23] and hence concomitantly modified
their surface characteristics (see below). The
influence of the aggregation state may also vary
with the cellular endpoint examined. We have e.g.
reported that the cytotoxic activity of nanosilica
particles towards macrophages was not affected by
their degree of aggregation [24] whereas their
membranolytic activity in erythrocytes decreased
with the degree of aggregation [25]. It should also be
considered that dispersants (tension-active agents,
proteins) act by modifying the surface properties of
the nanoparticles and hence modify their surface
reactivity; it might therefore be difficult to determine
whether a response change recorded after adding
a dispersant is due to the dispersion state or to
surface modification. High energy sonication can
also produce free radicals that initiate a variety of
chemical reactions in the culture medium and might
modify the NM or be a confounding source of
cytotoxicity [26]. Hence, we should keep in mind
that changing one NM parameter may cause a chain
reaction leading to the modification of several other
parameters. Given the complexity of the dispersion
issue, no single recipe can be recommended and
investigators should strive to rationally justify if
and how to disperse their NM.
4. Which metric to express the dose?
Expression of the dose in nanotoxicology remains
another difficult issue as there is no agreement on
the most appropriate approach, probably reflecting
the fact that different situations require different
approaches. However, the idea that “effects of NM
are not related to the mass dose” is not correct.
Most investigators report the gravimetric dose
(μg/ml culture medium, μg/cm2 culture well, μg/106
cells, …), and this is probably a reasonable initial
choice to verify that a cellular response to a given
NM is a dose-dependent phenomenon. For a given
NM, a dose-effect/response relationship can often
be evidenced with the mass dose, even if the most
relevant metric is particle surface area or number
because those metrics are inter-related. A
confounding effect may, however, arise when
comparing several NM and it might be appropriate
to consider another metric than mass to better
compare samples. For instance, when it appears that
cytotoxicity is driven by the release of reactive
oxygen species, this is generally a surface-driven
phenomenon for insoluble NM and the results
should be normalized for the specific surface area.
The surface area dose is, in contrast, probably not
appropriate for NM exerting their toxicity through
the release of soluble ions (see above ZnO, CuO,
CoO) and mass dose should be preferred in this
case (although solubility might be a function of
surface area).
How to express the dose of high aspect ratio NM
(HARN) such as carbon nanotubes is even more
conjectural. By analogy with what we know from the
conventional toxicology of fibres, it would appear
sensible that the most relevant metric to
characterize the dose-effect/response relationships
for HARN is the number of “fibres”. There is,
however, no consensus on what is a “carbon nanotube
fibre”: single nanotubes, ropes or aggregates of
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nanotubes, long nanotubes, long ropes? This is a
very difficult question that will need to be adequately
addressed as it directly impacts regulatory aspects
such as the definition of an occupational exposure
limit (OEL) for carbon nanotubes.
For every complex problem there is an answer that is
clear, simple, and wrong
H.L. Mencken
Thus, we have accumulated experience and knowledge
in nanotoxicology and the core assumption of Paracelsus
remains robustly valid in the field. Designing, perform-
ing and mainly interpreting a nanotoxicology experiment
in vitro is, however, a complex venture that requires
controlling many parameters. We should not be under
the illusion that simple and univocal recipes exist, and
the reliable implementation of high throughput systems
for evaluating the health hazard of NM should be ex-
pected in the long-term rather than in the near future.
Investigators should recognize this complexity and inte-
grate the need for critically adapting implemented proto-
cols and metrics according to the research question, the
type of NM investigated, and, possibly, analogies based
on knowledge about mechanisms of action.
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